Unlock instant, AI-driven research and patent intelligence for your innovation.

Pyridoazepine derivatives, pharmaceutical compositions and applications thereof

A compound, pharmaceutical technology, applied in the direction of drug combinations, active ingredients of heterocyclic compounds, antipyretics, etc.

Active Publication Date: 2021-05-14
SHANGHAI DE NOVO PHARMA
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although there have been many studies on TLRs, there are still great opportunities to further expand their use and advantages

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pyridoazepine derivatives, pharmaceutical compositions and applications thereof
  • Pyridoazepine derivatives, pharmaceutical compositions and applications thereof
  • Pyridoazepine derivatives, pharmaceutical compositions and applications thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0125] Embodiment 1: the synthesis of compound 1.8

[0126]

[0127] Step 1: Under ice-bath conditions, drop into a tetrahydrofuran (400 mL) solution of 2-amino-6-chloropyridine (40.0 g, 311 mmol) and lithium bistrimethylsilylamide (685 mL, 685 mmol, 1M tetrahydrofuran solution) Add di-tert-butyl dicarbonate (74.7 g, 342 mmol). The reaction system was stirred overnight at room temperature and then concentrated, diluted with ethyl acetate (400 mL), the organic phase was washed with hydrochloric acid solution (1M), saturated aqueous sodium bicarbonate solution and saturated brine, and the organic phase was separated with anhydrous sulfuric acid Sodium-dried, filtered and concentrated, the obtained residue was recrystallized from ethanol, filtered, and the filter cake was dried to obtain compound 1.1 (39.5 g, yield: 56%) as a yellow solid.

[0128] Step 2: Under nitrogen protection, a solution of compound 1.1 (39.5g, 173mmol) and N,N,N',N'-tetramethylethylenediamine (74.4g, 4...

Embodiment 2

[0135] Embodiment 2: the synthesis of compound 2.11

[0136]

[0137] Step 1: 3-bromo-2-chloro-6-methyl-5-nitropyridine (9.0g, 35.8mmol) and stannous chloride (27.2g, 143mmol) were added to ethanol (300mL), and the reaction system The temperature was raised to 80°C and stirred for 3 hours. Concentrate the reaction solution under reduced pressure, dilute with ethyl acetate (400mL), wash the organic phase with aqueous sodium hydroxide solution (1M), filter, extract the filtrate with ethyl acetate (4×100mL), combine the organic phases and wash with saturated brine Wash, dry over anhydrous sodium sulfate, filter, and concentrate under reduced pressure to obtain compound 2.1 (7.3 g, yield: 92%) as a yellow solid.

[0138] Step 2: Compound 2.1 (7.3 g, 33.0 mmol) was added into a mixed solution of acetic anhydride (40 mL) and glacial acetic acid (20 mL), and stirred overnight at room temperature. The reaction solution was concentrated under reduced pressure to obtain compound 2....

Embodiment 3

[0148] Embodiment 3: the synthesis of compound 3.2

[0149]

[0150] Step 1: N, The N-dimethylformamide (10mL) solution was stirred at 50°C for 5 hours, the reaction system was cooled to room temperature and poured into water, the solid was collected by filtration, the filter cake was washed with water and petroleum ether, and dried under reduced pressure to obtain compound 3.1 ( 0.84 g, Yield: 78%) as a yellow solid.

[0151] Step 2: Under the protection of nitrogen, compound 3.1 (500mg, 1.63mmol), potassium acetate (481mg, 4.9mmol), biboronic acid pinacol ester (622mg, 2.45mmol) and Pd(dppf) 2 Cl 2 (11.9 mg, 0.02 mmol) in 1,4-dioxane (10 mL) was stirred at 80°C for 4 hours. The reaction system was cooled to room temperature, filtered with diatomaceous earth, rinsed with ethyl acetate solution, the filtrate was concentrated, the obtained residue was slurried with ethanol, the solid was collected by filtration, and dried under reduced pressure to obtain compound 3.2 (528...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pyridoazepine derivative, its pharmaceutical composition and application. The pyridazepine derivative (I), its isomer, prodrug, stable isotope derivative or pharmaceutically acceptable salt of the present invention has the following structure. The pyridoazepine derivatives of the present invention have a good regulatory effect on the TLR family and related signaling pathways, especially on TLR8, and can effectively treat, relieve and / or prevent TLR family and TLR-related diseases. Various diseases mediated by signaling pathways, especially various diseases mediated by TLR8 can be effectively treated, relieved and / or prevented, such as cancer, autoimmune diseases, infection, inflammation, transplant rejection, graft-versus-host disease, etc.

Description

technical field [0001] The invention relates to a pyridazepine derivative, its pharmaceutical composition and application. Background technique [0002] The Toll-like receptor family (TLRs) is an important protein family that recognizes pathogen-associated molecular patterns, can sense and initiate innate immune responses and promote the development of adaptive immune responses. TLRs are mainly expressed in immune cells, such as myeloid dendritic cells (mDC), plasma dendritic cells (pDC), monocytes and B cells (Kawai and Akira, 2010) and the lung. In humans, more than 10 TLRs are thought to have significant functions. TLR1 / 2 / 4 / 5 and 6 are located in the cell membrane, and their main function is to recognize extracellular macromolecule ligands from bacteria and fungi. In contrast, TLR3 / 7 / 8 / 9 is located in the endosomal membrane in cells, and its main function is to recognize exogenous nucleic acids from pathogen cells. Although most TLRs function through specific signaling...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D471/04A61K31/55A61P35/00A61P29/00A61P37/02A61P37/06A61P31/16A61P31/14A61P31/20A61P31/22A61P31/18A61P35/02
Inventor 高大新杨和平陈寿军高亚樵王龙生
Owner SHANGHAI DE NOVO PHARMA